Literature DB >> 3451215

Coagulation abnormalities in patients with eosinophilia.

J J Vázquez1, A Fernández Pavón, F Arnalich, A Gil, A López Pastor, M S García Muñoz, J M Peña, F J Barbado.   

Abstract

Haematological variables in patients with eosinophilia and in healthy control subjects were studied in order to determine whether there were abnormalities in the coagulation system in patients. We found significantly elevated levels of fibrinogen, fibrin degradation products, platelet number and beta-thromboglobulin in patients. The abnormalities were not related to the causes of eosinophilia nor to its severity. This lack of correlation could be due to the heterogeneity of human peripheral blood eosinophils.

Entities:  

Mesh：

Year:  1987        PMID： 3451215      PMCID： PMC2428729          DOI： 10.1136/pgmj.63.745.943

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  11 in total

1.  A test of platelet adhesiveness.

Authors:  E J Bowie; C A Owen; J H Thompson; P Didisheim
Journal:  Mayo Clin Proc       Date:  1969-05       Impact factor: 7.616

Review 2.  [Beta-thromboglobulin and platelet factor 4. A review].

Authors:  C L Arocha-Piñango; A Ojeda
Journal:  Sangre (Barc)       Date:  1983

3.  Clinical features of fifteen patients with the hypereosinophilic syndrome.

Authors:  C J Spry; J Davies; P C Tai; E G Olsen; C M Oakley; J F Goodwin
Journal:  Q J Med       Date:  1983

4.  Studies on liberation of beta-thromboglobulin from human platelets in vitro.

Authors:  C A Ludlam; J D Cash
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

5.  Enhancement of factor XII dependent reactions by eosinophil cationic protein.

Authors:  P Venge; R Dahl; R Hällgren
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

6.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

Review 7.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

8.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

9.  Purification and binding properties of human platelet factor four.

Authors:  R I Handin; H J Cohen
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

10.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.

Authors:  L Prin; M Capron; A B Tonnel; O Bletry; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1983
View more
  3 in total

1.  Restrictive cardiomyopathy in a cat with hypereosinophilic syndrome.

Authors:  B Saxon; M Hendrick; J R Waddle
Journal:  Can Vet J       Date:  1991-06       Impact factor: 1.008

Review 2.  Eosinophils and disease pathogenesis.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

3.  Eosinophilia: Rare cause of arterial thrombosis and cardioembolic stroke in childhood.

Authors:  Sanjeev Kumar Sharma; Suman Kumar; Tulika Seth; Pravas Mishra; Manoranjan Mahapatra
Journal:  World J Cardiol       Date:  2012-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.